as on November 6, 2025 at 2:29 am IST
Day's Low
Day's High
1.48%
Downside
0.35%
Upside
52 Week's Low
52 Week's High
18.48%
Downside
19.80%
Upside
Check Resmed Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$36.3B
EPS (TTM)
9.5009
Dividend Yield
0.81%
Quarterly Earnings Growth YOY
0.12%
PE Ratio (TTM)
25.51
Industry PE ratio
19.200384615384614
PEG Ratio
1.8635
EBITDA
1.9B
Revenue (TTM)
5.3B
Profit Margin
27.35%
Return On Equity TTM
25.41%
Track how Resmed Inc. P/E has moved over time to understand its valuation trends.
Resmed Inc. in the last 5 years
Lowest (22.59x)
December 31, 2023
Industry (19.20x)
November 5, 2025
Today (25.51x)
November 5, 2025
Highest (49.09x)
September 30, 2021
Today’s Price to Earnings Ratio: 25.51x
Compare market cap, revenue, PE, and other key metrics of Resmed Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $36.3B | 15.78% | 25.51 | 27.35% | |
| BUY | $192.9B | 121.96% | 71.99 | 28.58% | |
| BUY | $20.1B | -2.74% | 41.51 | 16.29% | |
| BUY | $36.5B | 19.78% | 34.2 | 10.70% | |
| BUY | $50.8B | -23.7% | 32.35 | 7.41% |
The Resmed Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Resmed Inc. investment value today
Current value as on today
₹1,05,152
Returns
₹5,152
(+5.15%)
Returns from Resmed Inc. Stock
Dollar Returns*
₹5,351 (+5.35%)
Based on 19 analysts
63.16%
Buy
36.84%
Hold
0.00%
Sell
Based on 19 analysts, 63.16% of analysts recommend a 'BUY' rating for Resmed Inc.. Average target price of $293.47
Get share price movements and forecasts by analysts on Resmed Inc..
What analysts predicted
16.43%UPSIDE
Target Price
$293.47
Current Price
$245.25
Analyzed by
19 Analysts
Target
$293.47
Resmed Inc. target price $293.47, a slight upside of 16.43% compared to current price of $245.25. According to 19 analysts rating.
Search interest for Resmed Inc. Stock has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 31 October
Fri, 06:21 PM
-Morgan Stanley raises ResMed's price target to $305 following better-than-expected Q1 results.
Fri, 06:54 PM
-ResMed beats Q1 earnings estimates with $2.55 EPS and $1.336 billion sales, reflecting strong performance and strategic progress.
Sat, 05:45 AM
-ResMed reports strong Q1 earnings with 9% revenue growth, despite challenges in SaaS and increased tax rates.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Intuitive Surgical, Inc. has given 4.5% return, outperforming this stock by 4.2%
Against Peers
![]()
In the last 3 years, Intuitive Surgical, Inc. has given 124.9% return, outperforming this stock by 108.1%
Profit Down
![]()
Resmed Inc. has experienced a decline in its net profit over the last two quarters. The net profit fell from $379.70 million to $348.53 million, reflecting an average decrease of 8.2% per quarter.
Revenue Fall
![]()
Resmed Inc. has experienced a decline in revenue over the last two quarters. The revenue decreased from $1.34 billion to $1.33 billion, reflecting an average decline of 0.9% per quarter.
Price Dip
![]()
In the last 1 month, RMD stock has moved down by -12.4%
| Organisation | Resmed Inc. |
| Headquarters | 9001 Spectrum Center Boulevard, San Diego, CA, United States, 92123 |
| Industry | Health Technology |
| CEO | Mr. Michael J. Farrell BE, MBA, SM |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Jim Ellis | Chief Compliance Officer |
Ms. Yvonne-Katrin Pucknat | Chief Marketing Officer |
Mr. Michael J. Farrell BE, MBA, SM | CEO & Chairman |
Mr. Brett A. Sandercock | Chief Financial Officer |
Mr. Alastair Robertson | Chief Information Officer |
Ms. Sallilyn Schwartz | Chief Investor Relations Officer |
Ms. Vered Keisar | Chief People Officer |
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD | Founder, Chair Emeritus & Non-Executive Director |
Mr. Michael J. Rider | Chief Legal Officer & Secretary |
Mr. Justin Leong | Chief Product Officer |
Resmed Inc. share price today is $245.25 as on at the close of the market. Resmed Inc. share today touched a day high of $246.1 and a low of $241.62.
Resmed Inc. share touched a 52 week high of $293.81 on and a 52 week low of $199.92 on . Resmed Inc. stock price today i.e. is closed at $245.25,which is 16.53% down from its 52 week high and 22.67% up from its 52 week low.
Resmed Inc. market capitalisation is $0.04T as on .
Indian investors can start investing in Resmed Inc. (RMD) shares with as little as ₹88.615 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.15 in Resmed Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Resmed Inc. share’s latest price of $245.25 as on November 6, 2025 at 2:29 am IST, you will get 0.0408 shares of Resmed Inc.. Learn more about
fractional shares .
Resmed Inc. stock has given 15.78% share price returns and 20.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?